Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
20,100
Employees20,100
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
20,100
Employees20,100

CRL Key Statistics

Market cap
10.81B
Market cap10.81B
Price-Earnings ratio
-141.29
Price-Earnings ratio-141.29
Dividend yield
Dividend yield
Average volume
870.55K
Average volume870.55K
High today
$227.51
High today$227.51
Low today
$218.98
Low today$218.98
Open price
$224.04
Open price$224.04
Volume
770.87K
Volume770.87K
52 Week high
$228.88
52 Week high$228.88
52 Week low
$91.86
52 Week low$91.86

Stock Snapshot

As of today, Charles River(CRL) shares are valued at $219.70. The company's market cap stands at 10.81B, with a P/E ratio of -141.29.

On 2026-01-17, Charles River(CRL) stock moved within a range of $218.98 to $227.51. With shares now at $219.70, the stock is trading +0.3% above its intraday low and -3.4% below the session's peak.

Trading activity shows a volume of 770.87K, compared to an average daily volume of 870.55K.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

CRL News

TipRanks 1d
Charles River price target raised to $265 from $200 at Citi

Citi analyst Patrick Donnelly raised the firm’s price target on Charles River (CRL) to $265 from $200 and keeps a Buy rating on the shares. The firm adjusted ta...

TipRanks 4d
Charles River Labs outlines 2026 outlook and acquisitions

Claim 70% Off TipRanks Premium The latest announcement is out from Charles River Labs ( (CRL) ). At the J.P. Morgan Conference, Charles River Laboratories rep...

Simply Wall St 4d
A Look At Charles River Laboratories Valuation As CEO Succession Plan Takes Shape

Charles River Laboratories International (CRL) has announced a major leadership transition, with long-time CEO James C. Foster scheduled to retire in May 2026 a...

A Look At Charles River Laboratories Valuation As CEO Succession Plan Takes Shape

Analyst ratings

55%

of 20 ratings
Buy
55%
Hold
40%
Sell
5%

More CRL News

Nasdaq 5d
Charles River Laboratories Announces Strategic Acquisitions And Leadership Appointment

(RTTNews) - Charles River Laboratories International Inc. (CRL) unveiled a series of strategic moves at the J.P. Morgan 44th Annual Healthcare Conference, inclu...

Charles River Laboratories Announces Strategic Acquisitions And Leadership Appointment
TipRanks 5d
Charles River to buy KF Cambodia for $510M, exercises option for Pathoquest

The company states: “Charles River (CRL) announced two planned acquisitions of K.F. (Cambodia) Ltd. and PathoQuest SAS; the addition of Dr. Namandje N. Bumpus a...

Simply Wall St 6d
Why Charles River Is Up 9.1% After Naming Long‑Time Insider Birgit Girshick CEO

Charles River Laboratories International announced that long‑time Chair, President and CEO James C. Foster will retire in May 2026, with current Chief Operating...

Why Charles River Is Up 9.1% After Naming Long‑Time Insider Birgit Girshick CEO

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .